“Current Trends in the Treatment of Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer”, J. Pharm. Nutr. Sci., vol. 10, no. 1, pp. 46–59, Jan. 2020, doi: 10.29169/1927-5951.2020.10.01.8.